Drug Type Small molecule drug |
Synonyms EGIS 5810, EGIS-5810, GYKI 51189 + [1] |
Target |
Action agonists |
Mechanism GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H17ClN2O2 |
InChIKeyVQYLGVVODFDFNK-UHFFFAOYSA-N |
CAS Registry82230-53-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Girisopam | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anxiety Disorders | Phase 1 | - | - | |
Anxiety Disorders | Phase 1 | - | - | |
Anxiety Disorders | Phase 1 | - | - | |
Depressive Disorder, Major | Phase 1 | - | - | |
Depressive Disorder, Major | Phase 1 | - | - | |
Depressive Disorder, Major | Phase 1 | - | - |